GENEVA, Aug. 21 -- THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE DIRECTOR OF THE DEFENSE HEALTH AGENCY filed a patent application (US2026/015234) for “METHODS FOR LARGE-SCALE MANUFACTURE OF ADJUVANT FORMULATIONS”. With publication no. WO/2026/174173, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 9/127
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....